Literatur
Oliver RT, Mason MD, Mead GM, von der Maase H, Rustin GJ, Joffe JK, de Wit R, Aass N, Graham JD, Coleman R, Kirk SJ, Stenning SP, TE19 collaborators, 30982 collaborators (2005) Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 366(9482):293–300
Tandstad T, Stahl O, Dahl O, Haugnes HS, Hakansson U, Karlsdottir A, Kjellman A, Langberg CW, Laurell A, Oldenburg J, Solberg A, Soderstrom K, Stierner U, Cavallin-Stahl E, Wahlqvist R, Wall N, Cohn-Cedermark G, Swenoteca (2016) Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA). Ann Oncol 27(7):1299–1304
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Schrader gibt an, dass kein Interessenkonflikt besteht.
Additional information
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Schrader, M. Surveillance bei Seminomen im Stadium 1 – eine evidenzbasierte Anleitung für die Praxis!. Urologie 62, 958–960 (2023). https://doi.org/10.1007/s00120-023-02130-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-023-02130-4